Name: IPO Advicenne
Uploaded: 2017-12-06T14:41:23+0100
Description: Listing of Advicenne on Euronext Dr. Luc-André Granier, CEO and co-founder of Advicenne, open the trading day in Paris. Advicenne specializes in the research and development of drugs for the treatment of neglected neurological and nephrological diseases, mostly among children.

Search Contact

This page is available in multiple languages

Select Language

Back

06/12/2017

Listing of Advicenne on Euronext

Dr. Luc-André Granier, CEO and co-founder of Advicenne, open the trading day in Paris.

Advicenne specializes in the research and development of drugs for the treatment of neglected neurological and nephrological diseases, mostly among children.